Prospective Observational Study for Efficacy of Perioperative Serum Glucose Level Evaluated by Continuous Glucose Monitoring System in Kidney Transplantation Patients
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- New Onset Diabetes After Transplantation
- Sponsor
- Seoul National University Hospital
- Enrollment
- 100
- Locations
- 1
- Primary Endpoint
- Rate of NODAT
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
his study aims to utilize Continuous Glucose Monitoring (CGM) to observe glucose fluctuations in kidney transplant recipients and predict New-Onset Diabetes After Transplantation (NODAT) based on these patterns. Additionally, it seeks to investigate glucose variability resulting from medications and surgeries such as immunosuppressants and steroid regimens post-kidney transplantation. This prospective observational study anticipates identifying factors influencing blood glucose levels and contributing to future research on blood glucose management using CGM monitoring in kidney transplant patients.
Investigators
Eligibility Criteria
Inclusion Criteria
- •The study will target 100 kidney transplant patients who have provided consent, among those who underwent the procedure at Seoul National University Hospital after March 2021.
Exclusion Criteria
- •multi-organ transplant
- •history of previous kidney transplant
- •less than 18 years old
Outcomes
Primary Outcomes
Rate of NODAT
Time Frame: 6 months after kidney transplantation
rate of new onset diabetes after transplantation